文献速递临床试验与 GCP流行病学与生物统计

急性缺血性卒中静脉溶栓后取栓的治疗时间与功能结局:一项Meta分析

Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis.
PubMed 文献 · JAMA · 2024-01-01

该个体参与者数据Meta分析纳入6项随机临床试验的2313例前循环大血管闭塞且适合静脉溶栓和取栓的卒中患者,比较静脉溶栓联合取栓与单纯取栓。结果显示,从症状发作到预期静脉溶栓给药的时间与治疗效果存在显著交互作用,联合治疗获益随时间延长而下降,仅在时间较短时具有统计学显著性。

要点

  • 静脉溶栓联合取栓的获益与症状发作至预期静脉溶栓给药时间显著相关。
  • 每延迟1小时,调整后共同OR比值为0.84(95%CI 0.72-0.97),交互作用P=0.02。
  • 超过2小时20分钟,联合治疗获益无统计学显著性,3小时14分钟时点估计值跨越无效线。

核心结论

  • 在具备取栓能力的卒中中心就诊的患者中,静脉溶栓联合取栓相对于单纯取栓的获益具有时间依赖性,仅当症状发作至预期静脉溶栓给药时间较短时才具有统计学显著性。

研究设计与样本

  • 个体参与者数据Meta分析,纳入6项比较静脉溶栓联合取栓与单纯取栓的随机临床试验,2017年1月至2021年7月在15个国家190个中心入组,共2334例适合静脉溶栓和取栓并直接就诊于具备取栓能力卒中中心的患者,本分析仅纳入前循环大血管闭塞患者2313例。

主要发现

  • 2313例参与者中,静脉溶栓联合取栓组1160例,单纯取栓组1153例;中位年龄71岁(IQR 62-78),女性占44.3%。
  • 症状发作至预期静脉溶栓给药的中位时间为2小时28分钟(IQR 1小时46分钟至3小时17分钟)。
  • 症状发作至预期静脉溶栓给药时间与分配治疗和功能结局的关联存在显著交互作用(每延迟1小时调整后共同OR比值0.84,95%CI 0.72-0.97,交互作用P=0.02)。
  • 静脉溶栓联合取栓的获益随症状发作至预期静脉溶栓给药时间延长而下降:1小时调整后共同OR为1.49(95%CI 1.13-1.96),2小时为1.25(95%CI 1.04-1.49),3小时为1.04(95%CI 0.88-1.23)。
  • mRS评分0、1或2的预测绝对风险差:1小时为9%(95%CI 3%-16%),2小时为5%(95%CI 1%-9%),3小时为1%(95%CI -3%-5%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The benefit of intravenous thrombolysis (IVT) for acute ischemic stroke declines with longer time from symptom onset, but it is not known whether a similar time dependency exists for IVT followed by thrombectomy. OBJECTIVE: To determine whether the benefit associated with IVT plus thrombectomy vs thrombectomy alone decreases with treatment time from symptom onset. DESIGN, SETTING, AND PARTICIPANTS: Individual participant data meta-analysis from 6 randomized clinical trials comparing IVT plus thrombectomy vs thrombectomy alone. Enrollment was between January 2017 and July 2021 at 190 sites in 15 countries. All participants were eligible for IVT and thrombectomy and presented directly at thrombectomy-capable stroke centers (n = 2334). For this meta-analysis, only patients with an anterior circulation large-vessel occlusion were included (n = 2313). EXPOSURE: Interval from stroke symptom onset to expected administration of IVT and treatment with IVT plus thrombectomy vs thrombectomy alone. MAIN OUTCOMES AND MEASURES: The primary outcome analysis tested whether the association between the allocated treatment (IVT plus thrombectomy vs thrombectomy alone) and disability at 90 days (7-level modified Rankin Scale [mRS] score range, 0 [no symptoms] to 6 [death]; minimal clinically important difference for the rates of mRS scores of 0-2: 1.3%) varied with times from symptom onset to expected administration of IVT. RESULTS: In 2313 participants (1160 in IVT plus thrombectomy group vs 1153 in thrombectomy alone group; median age, 71 [IQR, 62 to 78] years; 44.3% were female), the median time from symptom onset to expected administration of IVT was 2 hours 28 minutes (IQR, 1 hour 46 minutes to 3 hours 17 minutes). There was a statistically significant interaction between the time from symptom onset to expected administration of IVT and the association of allocated treatment with functional outcomes (ratio of adjusted common odds ratio [OR] per 1-hour delay, 0.84 [95% CI, 0.72 to 0.97], P = .02 for interaction). The benefit of IVT plus thrombectomy decreased with longer times from symptom onset to expected administration of IVT (adjusted common OR for a 1-step mRS score shift toward improvement, 1.49 [95% CI, 1.13 to 1.96] at 1 hour, 1.25 [95% CI, 1.04 to 1.49] at 2 hours, and 1.04 [95% CI, 0.88 to 1.23] at 3 hours). For a mRS score of 0, 1, or 2, the predicted absolute risk difference was 9% (95% CI, 3% to 16%) at 1 hour, 5% (95% CI, 1% to 9%) at 2 hours, and 1% (95% CI, -3% to 5%) at 3 hours. After 2 hours 20 minutes, the benefit associated with IVT plus thrombectomy was not statistically significant and the point estimate crossed the null association at 3 hours 14 minutes. CONCLUSIONS AND RELEVANCE: In patients presenting at thrombectomy-capable stroke centers, the benefit associated with IVT plus thrombectomy vs thrombectomy alone was time dependent and statistically significant only if the time from symptom onset to expected administration of IVT was short.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Kaesmacher J, Cavalcante F, Kappelhof M, et al. Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis. JAMA. 2024. PMID: 38324409. doi:10.1001/jama.2024.0589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。